David J. Kuter

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Hanny Al‐Samkari, Rebecca S. Karp Leaf, Jonathan Carlson et al. · Blood · 2020 · 1.4K citations · Full text

Medicine, Hematology, Infectious Diseases +13

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold et al. · Blood Advances · 2019 · 1.3K citations · Full text

Medicine, Hematology, Evidence-based Practice +12

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Drew Provan, Donald M. Arnold, James B. Bussel et al. · Blood Advances · 2019 · 1.1K citations · Full text

Medicine, Hematology, Pediatrics +13

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 862 citations

Medicine, Hematology, Pharmacology +6